1
|
Effects coding in discrete choice experiments.
|
Health Econ
|
2005
|
1.82
|
2
|
Societal views on orphan drugs: cross sectional survey of Norwegians aged 40 to 67.
|
BMJ
|
2010
|
1.80
|
3
|
Number needed to treat: easily understood and intuitively meaningful? Theoretical considerations and a randomized trial.
|
J Clin Epidemiol
|
2002
|
1.79
|
4
|
Influenza pandemic: perception of risk and individual precautions in a general population. Cross sectional study.
|
BMC Public Health
|
2007
|
1.24
|
5
|
Danish GPs' perception of disease risk and benefit of prevention.
|
Fam Pract
|
2002
|
1.19
|
6
|
Preference heterogeneity and choice of cardiac rehabilitation program: results from a discrete choice experiment.
|
Health Policy
|
2007
|
1.15
|
7
|
International comparison of the definition and the practical application of health technology assessment.
|
Int J Technol Assess Health Care
|
2005
|
1.14
|
8
|
Can postponement of an adverse outcome be used to present risk reductions to a lay audience? A population survey.
|
BMC Med Inform Decis Mak
|
2007
|
1.11
|
9
|
Insensitivity to scope in contingent valuation studies: reason for dismissal of valuations?
|
Appl Health Econ Health Policy
|
2012
|
1.08
|
10
|
Laypersons' understanding of relative risk reductions: randomised cross-sectional study.
|
BMC Med Inform Decis Mak
|
2008
|
1.07
|
11
|
Conjoint analysis. The cost variable: an Achilles' heel?
|
Health Econ
|
2003
|
1.06
|
12
|
Waist circumference and body mass index as predictors of health care costs.
|
PLoS One
|
2008
|
1.05
|
13
|
Communicating risk using absolute risk reduction or prolongation of life formats: cluster-randomised trial in general practice.
|
Br J Gen Pract
|
2014
|
1.05
|
14
|
Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.
|
Int J Cancer
|
2013
|
1.03
|
15
|
Preference for practice: a Danish study on young doctors' choice of general practice using a discrete choice experiment.
|
Eur J Health Econ
|
2013
|
1.03
|
16
|
Time-trends in health technology assessments: an analysis of developments in composition of international health technology assessments from 1989 to 2002.
|
Int J Technol Assess Health Care
|
2005
|
1.02
|
17
|
Ordering effect and price sensitivity in discrete choice experiments: need we worry?
|
Health Econ
|
2006
|
0.99
|
18
|
Increasing participation in cervical cancer screening: telephone contact with long-term non-attendees in Sweden. Results from RACOMIP, a randomized controlled trial.
|
Int J Cancer
|
2013
|
0.98
|
19
|
Comparing hospital costs: what is gained by accounting for more than a case-mix index?
|
Soc Sci Med
|
2009
|
0.96
|
20
|
Do general practitioners know patients' preferences? An empirical study on the agency relationship at an aggregate level using a discrete choice experiment.
|
Value Health
|
2012
|
0.93
|
21
|
Estimating the Danish populations' preferences for pharmacogenetic testing using a discrete choice experiment. The case of treating depression.
|
Value Health
|
2008
|
0.93
|
22
|
Organisational determinants of production and efficiency in general practice: a population-based study.
|
Eur J Health Econ
|
2011
|
0.92
|
23
|
Estimating a WTP-based value of a QALY: the 'chained' approach.
|
Soc Sci Med
|
2013
|
0.91
|
24
|
General practitioners' preferences for the organisation of primary care: a discrete choice experiment.
|
Health Policy
|
2012
|
0.90
|
25
|
Communicating effectiveness of intervention for chronic diseases: what single format can replace comprehensive information?
|
BMC Med Inform Decis Mak
|
2008
|
0.89
|
26
|
Willingness to pay for allergy-vaccination among Danish patients with respiratory allergy.
|
Int J Technol Assess Health Care
|
2010
|
0.87
|
27
|
Communicating treatment effectiveness in the context of chronic disease processes.
|
Expert Rev Pharmacoecon Outcomes Res
|
2006
|
0.87
|
28
|
Trends in time to invasive examination and treatment from 2001 to 2009 in patients admitted first time with non-ST elevation myocardial infarction or unstable angina in Denmark.
|
BMJ Open
|
2014
|
0.86
|
29
|
Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: a population-based survey.
|
BMC Med Inform Decis Mak
|
2012
|
0.84
|
30
|
Do informal caregivers in mental illness feel more burdened? A comparative study of mental versus somatic illnesses.
|
Scand J Public Health
|
2011
|
0.84
|
31
|
Economic costs of abdominal obesity.
|
Obes Facts
|
2008
|
0.83
|
32
|
Patient related outcomes in a real life prospective follow up study: Allergen immunotherapy increase quality of life and reduce sick days.
|
World Allergy Organ J
|
2013
|
0.83
|
33
|
Increasing marginal utility of small increases in life-expectancy? Results from a population survey.
|
J Health Econ
|
2010
|
0.83
|
34
|
The impact of population ageing on future Danish drug expenditure.
|
Health Policy
|
2005
|
0.82
|
35
|
Differences in general practice initiated expenditures across Danish local health authorities-A multilevel analysis.
|
Health Policy
|
2009
|
0.81
|
36
|
Characteristics of patients receiving allergy vaccination: to which extent do socio-economic factors play a role?
|
Eur J Public Health
|
2010
|
0.81
|
37
|
Patient preferences for pharmacogenetic screening in depression.
|
Int J Technol Assess Health Care
|
2008
|
0.81
|
38
|
Radiation from mobile phone systems: Is it perceived as a threat to people's health?
|
Bioelectromagnetics
|
2009
|
0.81
|
39
|
Exploring the relationship between costs and quality: does the joint evaluation of costs and quality alter the ranking of Danish hospital departments?
|
Eur J Health Econ
|
2010
|
0.80
|
40
|
Short and long-term labour market consequences of coronary heart disease: a register-based follow-up study.
|
Eur J Cardiovasc Prev Rehabil
|
2009
|
0.80
|
41
|
Willingness-to-pay for a population program aimed at reducing dietary salt in Denmark.
|
Prev Med
|
2006
|
0.80
|
42
|
The influence of information and private versus public provision on preferences for screening for prostate cancer: a willingness-to-pay study.
|
Health Policy
|
2011
|
0.80
|
43
|
Future costs in cost-effectiveness analysis: an empirical assessment.
|
Eur J Health Econ
|
2010
|
0.80
|
44
|
Does the EQ-5D measure quality of life in schizophrenia?
|
J Ment Health Policy Econ
|
2011
|
0.79
|
45
|
Costs of heart disease and risk behaviour: implications for expenditure on prevention.
|
Scand J Public Health
|
2008
|
0.79
|
46
|
Effects of alternative styles of risk information on EMF risk perception.
|
Bioelectromagnetics
|
2010
|
0.79
|
47
|
Individual decision making in relation to participation in cardiovascular screening: a study of revealed and stated preferences.
|
Scand J Public Health
|
2013
|
0.79
|
48
|
Cost-effectiveness of alendronate in the prevention of osteoporotic fractures in Danish women.
|
Basic Clin Pharmacol Toxicol
|
2005
|
0.78
|
49
|
Impact of effectiveness information format on patient choice of therapy and satisfaction with decisions about chronic disease medication: the "Influence of intervention Methodologies on Patient Choice of Therapy (IMPACT)" cluster-randomised trial in general practice.
|
BMC Health Serv Res
|
2013
|
0.78
|
50
|
Does access to invasive examination and treatment influence socioeconomic differences in case fatality for patients admitted for the first time with non-ST-elevation myocardial infarction or unstable angina?
|
EuroIntervention
|
2016
|
0.78
|
51
|
Are people who claim compensation "cured by a verdict"? A longitudinal study of health outcomes after whiplash.
|
J Law Med
|
2012
|
0.77
|
52
|
[Obesity related health care costs assessed from BMI or waist circumference--secondary publication].
|
Ugeskr Laeger
|
2009
|
0.77
|
53
|
NNT is not easily understood.
|
Fam Pract
|
2002
|
0.77
|
54
|
Prenatal screening for cystic fibrosis: an economic analysis.
|
Health Econ
|
2002
|
0.76
|
55
|
Norwegian obstetricians' opinions about cesarean section on maternal request: should women pay themselves?
|
Acta Obstet Gynecol Scand
|
2010
|
0.76
|
56
|
Investigating patients' preferences for cardiac rehabilitation in Denmark.
|
Int J Technol Assess Health Care
|
2006
|
0.76
|
57
|
Handling value added tax (VAT) in economic evaluations: should prices include VAT?
|
Appl Health Econ Health Policy
|
2006
|
0.76
|
58
|
[Association between productivity, list size, patient and practice characteristics in general practice].
|
Ugeskr Laeger
|
2010
|
0.75
|
59
|
Does the primary screening test influence women's anxiety and intention to screen for cervical cancer? A randomized survey of Norwegian women.
|
BMC Public Health
|
2014
|
0.75
|
60
|
The concept of risk: a comment to Reventlow and co-workers.
|
Scand J Prim Health Care
|
2002
|
0.75
|
61
|
Benign breast disease and breast cancer.
|
N Engl J Med
|
2005
|
0.75
|
62
|
Cost-effectiveness analysis based on the number-needed-to-treat: common sense or non-sense?
|
Health Econ
|
2004
|
0.75
|
63
|
[Prioritization and health--should maximum-price life years be introduced?].
|
Tidsskr Nor Laegeforen
|
2007
|
0.75
|
64
|
GPs as citizens' agents: prescription behavior and altruism.
|
Eur J Health Econ
|
2008
|
0.75
|
65
|
The potential of smoking cessation programmes and a smoking ban in public places: comparing gain in life expectancy and cost effectiveness.
|
Scand J Public Health
|
2011
|
0.75
|
66
|
[General practitioners' perception of disease risks and benefit of prevention].
|
Ugeskr Laeger
|
2002
|
0.75
|
67
|
Graded pairs comparison - does strength of preference matter? Analysis of preferences for specialised nurse home visits for pain management.
|
Health Econ
|
2007
|
0.75
|
68
|
Do guidelines recommending pharmacogenetic testing of psychiatric patients affect treatment costs and the use of healthcare services?
|
Scand J Public Health
|
2011
|
0.75
|
69
|
Valuation of morbidity and mortality risk reductions. Does context matter?
|
Accid Anal Prev
|
2012
|
0.75
|